General Information of Drug (ID: DM3JBLK)

Drug Name
PIK-93 Drug Info
Synonyms PIK93; PIK 93
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
6852167
CAS Number
CAS 593960-11-3
TTD Drug ID
DM3JBLK

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
GSK3923868 DMLDJ31 Chronic obstructive pulmonary disease CA22 Phase 1 [3]
GSK3923868 DMLDJ31 Chronic obstructive pulmonary disease CA22 Phase 1 [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Phosphatidylinositol-4-kinase beta (PI4KB) TTNPL3B PI4KB_HUMAN Inhibitor [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6062).
2 A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell. 2006 May 19;125(4):733-47.
3 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2023. Adis Insight
4 Clinical pipeline report, company report or official report of GlaxoSmithKline